FAHD2B Gene: Structure, Function, and Clinical Significance
A comprehensive overview of the FAHD2B gene, including its genomic location, protein function, expression patterns, and associated diseases.
Gene Information Card
| Symbol | FAHD2B |
|---|---|
| Full Name | fumarylacetoacetate hydrolase domain containing 2B |
| Gene Type | protein coding |
| Chromosomal Location | 2q11.2 |
| NCBI Gene ID | 388753 ncbi.nlm.nih.gov/gene/388753 |
| Ensembl ID | ENSG00000185883 |
| UniProt ID | Q6P2E0 |
| OMIM ID | 616276 |
| HGNC ID | 28313 |
| Aliases | FLJ32731, MGC26717 |
Description
FAHD2B (fumarylacetoacetate hydrolase domain containing 2B) is a protein-coding gene located on chromosome 2q11.2. The encoded protein belongs to the FAH (fumarylacetoacetate hydrolase) superfamily, which is characterized by a conserved catalytic domain involved in hydrolase activity. While the exact physiological function of FAHD2B is not fully characterized, it is predicted to play a role in metabolic processes, potentially involving the hydrolysis of specific substrates. The gene is expressed in various tissues, with notable levels in the kidney and liver. Alterations in FAHD2B expression or function may be implicated in certain pathological conditions, although detailed clinical associations are still under investigation.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Disease | Mechanism | Evidence |
| No specific disease association | Not established | No curated disease association found in OMIM or ClinVar as of the knowledge cutoff. |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Tissue | nTPM | Level |
| Kidney | 15.2 | Medium |
| Liver | 10.5 | Low |
| Testis | 8.3 | Low |
| Brain | 5.1 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| Cell Line | nTPM | Notes |
| HEK 293 | 12.0 | Embryonic kidney cells; moderate expression |
| HepG2 | 9.5 | Liver cancer cells; low expression |
| A549 | 6.2 | Lung carcinoma cells; low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| Variant | Type | Frequency | Effect |
| rs143912785 | SNV (missense) | 0.001 (global) | Amino acid substitution; potential impact on protein function (not clinically validated) |
| rs148978354 | SNV (synonymous) | 0.002 (global) | No amino acid change; likely benign |
Mutation functional classification
Loss of Function (LOF)
No loss-of-function mutations have been characterized for FAHD2B in the literature or databases.
Gain of Function (GOF)
No gain-of-function mutations have been reported.
Dominant Negative (DN)
No dominant-negative effects have been described.
View complete mutation data:
Gene Ontology (GO)
| • hydrolase activity | • metal ion binding |
| • catalytic activity |
Pathways
• Tyrosine metabolism (predicted
• based on FAH domain)
• Metabolic pathways (general)
Protein Summary
The FAHD2B protein is a member of the fumarylacetoacetate hydrolase (FAH) superfamily, characterized by a conserved alpha/beta hydrolase fold. It is predicted to possess hydrolase activity, potentially acting on carbon-nitrogen bonds (other than peptide bonds). The protein is localized in the cytoplasm and may be involved in metabolic processes, particularly in the breakdown of aromatic amino acids. However, its specific substrates and physiological roles remain to be fully elucidated. Structural studies suggest the presence of a metal-binding site, likely coordinating a divalent cation essential for catalysis.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| FAHD2B Knockout HEK293 Cell Line | EDJ-KQ11328 | Human | 151313 | Details Get a Quote |
| FAHD2B Knockout A-549 Cell Line | EDJ-KQ39482 | Human | 151313 | Details Get a Quote |
| FAHD2B Knockout HCT 116 Cell Line | EDJ-KQ39483 | Human | 151313 | Details Get a Quote |
| FAHD2B Knockout HeLa Cell Line | EDJ-KQ39484 | Human | 151313 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records